HuagongsheHuagongshe Chemistry Print Report · For research reference only
Raltegravir → 4-Fluorobenzylamine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Raltegravir | HCID 54671008 | — |
| Reactant | 1446223-96-6 | HCID 136236480 | — |
| Product | 4-Fluorobenzylamine | HCID 67326 | — |
| Product | HCID 136502909 | HCID 136502909 | — |
Reaction Steps
Among the advantages of the novel route of synthesis of raltegravir is the regioselective methylation of N-(4-fluorobenzyl)-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-1,6-dihydro-5-hydroxy-6-oxopyrimidine-4-carboxamide (VI) obtained by amidation of methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-1,6-dihydro-5-hydroxy-6-oxopyrimidine-4-carboxylate (Va) with p-fluorobenzyl amine. The methylation reaction provides regioselectivity of more than 99% as against methylation of oxygen at 6th position, thereby resulting in a higher yield of more than 90%. The yield for the methylation reaction is in the range of 88 to 90%.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09403809B2 |
| Source dataset | uspto-grants-2016_08 |
| ORD ID | ord-f3d6f93e7d514351bf3c2e4523edfa9f |
| Source note | uspto-grants-2016_08 |